Edison Liu


Edison T. Liu, M.D., is the president and CEO of , and was the president of Human Genome Organization, HUGO from 2007-2013.
Between 1997 and 2001, he was the scientific director of the National Cancer Institute's Division of Clinical Sciences in Bethesda, Md., where he was in charge of the intramural clinical translational science programs. From 1987 to 1996, Dr. Liu was a faculty member at the University of North Carolina at Chapel Hill, where he was the director of the UNC Lineberger Comprehensive Cancer Center's Specialized Program of Research Excellence in Breast Cancer; the director of the Laboratory of Molecular Epidemiology at UNC's School of Public Health; chief of Medical Genetics; and the chair of the Correlative Science Committee of the national cooperative clinical trials group, CALGB.
Liu is an international expert in cancer biology, genomics, human genetics, molecular epidemiology and translational medicine. Dr. Liu's own scientific research has focused on the functional genomics of human cancers, particularly breast cancer, uncovering new oncogenes, and deciphering the dynamics of gene regulation on a genomic scale that modulate cancer biology. He has authored over 300 scientific papers and reviews, and co-authored two books.
In his spare time, Liu pursues jazz piano and composition, and writes for the lay public on science, medicine and society.

Education

1983-1987
Postdoctoral Fellow - Dept. of Microbiology, University of California at San Francisco, CA
1982-1985
Hematology Fellowship, University of California San Francisco, Moffitt Hospital
1980-1982
Oncology Fellowship, Stanford University
1979-1980
Residency, Barnes Hospital - Washington University, St. Louis
1978-1979
Internship, Barnes Hospital - Washington University, St. Louis
1973-1978
Stanford University, M.D.
1969-1973
Stanford University, B.S. Chemistry, Psychology

Professional Appointments

President and CEO of The Jackson Laboratory
2001-2011
Executive Director, Genome Institute of Singapore
2007
Visiting Scientist, RIKEN Institute, Japan
Nov 2006–present
Adjunct Professor of Johns Hopkins, Division of Molecular Medicine, Department of Medicine
Present
Adjunct Professor of Molecular and Cellular Biology at the University of Champaign-Urbana.
1996-2001
Director, Division of Clinical Sciences, National Cancer Institute, Bthesda, MD
1995-1996
Chief, Division of Medical Genetics, School of Medicine
1995-1996
Professor, Departments of Medicine, Epidemiology, Biochemistry and Biophysics.
1993-1995
Associate Professor, Departments of Medicine and Epidemiology and Biochemistry, University of North Carolina at Chapel Hill
1992-1996
Director, Specialized Program of Research Excellence in Breast Cancer
1987-1993
Assistant Professor in Medicine and Oncology, School of Medicine University of North Carolina at Chapel Hill

Honors and awards

2016
Honorary Degree recipient, Colby College
2016 Elected Fellow, American Association for the Advancement of Science
2008
Associate Member European Molecular Biology Organization
2007
Doctor of Medical Science honoris causa - Awarded by Queen's University Belfast
2005
National Healthcare Group, Singapore, Distinguished Contributor Award
2003
Public Service Medal : for work in controlling SARS in Singapore
2000
Rosenthal Award, AACR: for the discovery that HER-2 status determines response to adjuvant chemotherapy with doxorubicin.
1999
Elected-Board of Directors, American Association for Cancer Research
1996
1996 Brinker International Award for Breast Cancer Research - Basic Research Award
1995
American Society of Clinical Investigation
1991-1996
Leukemia Society Scholar
1990-1994
Jefferson Pilot Award: University of North Carolina at Chapel Hill, Junior Faculty Award for Research Excellence
1990-1993
Komen Foundation Award for Breast Cancer Research
1985-1988
Clinical Investigator Award, National Cancer Institute, K08-CA01036-02, Preceptor: Dr. J. Michael Bishop.
1983-1985
Damon Runyan Cancer Fund Fellowship Preceptor: Dr. J. Michael Bishop
1974
Ford Foundation Fellowship for Intensive Studies in Chinese, Stanford University
1973
Phi Beta Kappa Stanford University
1972
National Science Foundation Fellowship in Chemistry 1972.
Hastings Center Fellow

Committee and Advisory Board

2007–present
President, HUGO
2007-2009
Chairman, Health Sciences Authority, Singapore
2007–present
Keystone Symposia Scientific Advisory Board
2006
Board Member, National Healthcare Group, Singapore
2006
Deputy Chairman, Health Sciences Authority, Singapore
2005-2008
Member, NUS High School Board of Governors
2006
Member, Editorial Advisory Board, Biomolecular Frontiers, National University of Singapore
2005
Member, Search Committee for Deputy President
2004
FANTOM3 working group member.
2004
University Autonomy, Governance, and Funding Steering Committee
2003
Bioethics Advisory Committee, Singapore
2002-2003
National Health Group, Strategic Committee for Clinical Research
2002
Biomedical Sciences Executive Committee, A*STAR
2002-2006
General Motors Award, General Assembly
2002
National University of Singapore: Feasibility study team for the establishment of a multicampus university.
2002
Ministerial committee to re-evaluate Singapore’s secondary school system
2001
President’s Life Sciences Committee
2001
University Promotion and Tenuring Committee
2001-2003
Genetically Modified Organisms Advisory Council
2000-2001
NCI-Ireland-Northern Ireland Cancer Consortium Governing Board
1999-2000
Chair, General Motors Cancer Research Awards Committee: Mott Award
1999-2001
NIH Committee to establish NIH graduate program
1998-2001
NIH Building 10 Revitalization Committee
1997-1998
NCI Breast Cancer Program Review Group
1997-2001
NIH Clinical Research Revitalization Committee
1997-2001
Co-Chair, NIH Clinical Center Advisory Council
1997
Chairman, NIH Committee on Extramural/Intramural Investigations in the Clinical Center
1997
Molecular Epidemiology Coordinating Group, NCI
1997
SBRS Policy Board, NIH
1996
AACR - Clinical Cancer Research Committee, 1996
1996
NCI - Clinical Trials Working Group, 1996
1996
NCI - Cancer Genetics Working Group, 1996
1996
NCI - Developmental Diagnostics Working Group, 1996
1996-1997
NIH Committee on the Recruitment and Career Development of Clinical Investigators
1996
Protocol Review and Monitoring Committee, NCI
1996
Faculty Search Committee, Division of Molecular Genetics
1996
Executive Committee: Clinical Cancer Program
1996
Advisory Committee: Clinical Cancer Program
1995-1996
National Action Plan on Breast Cancer - Biological Resources Working Group
1994
Faculty Search Committee: Cell Biology Program, Lineberger Cancer Center
1992-1994
American Society for Clinical Oncology: Program Committee
1990-1992
Lineberger Cancer Center, SPA personnel compensation Committee
1992
Faculty Search Committee Program in Molecular Biology
1990
Lineberger Cancer Center Planning Committee 14th Annual Symposium
1989
Lineberger Cancer Center Seminar Committee